Trending Sources

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

But the San Diego data was off. million in 19 companies in San Diego. million invested in 23 San Diego companies.

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent

Xconomy

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

Santa Barbara, San Diego Tops On Per-Capita Venture Capital

socalTECH

San Diego-Carlsbad-San Marcos was number 7, with $36.6M in deals and 3.3 San Jose-Sunnyvale-Santa Clara; 2. READ MORE>>.

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning

Xconomy

Nervana, which now has 48 employees, plans to remain in San Diego and operate under its own brand name.

Dauntless Takes Flight with New Business Model for Starting Biotechs

Xconomy

All of the company’s funding so far has come from Sofinnova Ventures, and Mike Powell, a Sofinnova general partner in San Francisco, is board chairman.

San Diego, Irvine Tops For Engineering Job Demand, Says Report

socalTECH

Two, Southern California markets-- San Diego and Irvine --are among the top ares for engineering job demand, according to a report today.

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

Xconomy

That means doctors should be able to use Watson to read and digest health records, lab results, radiology reports, and relevant medical literature.

IBM 30

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA

Xconomy

Heather and Jessica Tomko will tell you that they’re nothing alike. They’ve got different interests, different tastes in movies, television, and music.

MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff

Xconomy

months in previously untreated elderly patients who received the drug.

Study 14

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —South San Francisco-based Second Genome hired a new CEO and president. The week started on a reflective note. And perhaps most important, there was the U.S. Or not.

News 25

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Talk about sacrifice.

Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug

Xconomy

Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101.

Study 14

Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

Xconomy

—Bruce Bigelow profiled Dauntless Pharmaceuticals , a stealthy biotech company creator in San Diego forming single-drug startups. —San Francisco gene therapy startup Audentes Pharmaceuticals (NASDAQ: BOLD ) raised $75 million in an IPO , selling 5 million shares at $15 apiece, right in its projected range.

Pharma’s Productivity Problem: Finding More Blockbuster Drugs

Xconomy

recent Silicon Valley Bank report noted that large corporations have dramatically increased pre-clinical acquisitions in the last three years under the pressure of limited supply and competition from IPOs.  The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

Xconomy

center led by the Scripps Research Institute in San Diego will work on ways for those individuals to participate.

PMI 18

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Xconomy

The wait continues. Will next week be the week a decision finally comes? Next month? Later today? Until then everyone sits, waits, and speculates.

Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More

Xconomy

STAT was among the outlets to report that Gilead has also quietly raised prices on older HIV drugs, ostensibly to drive prescriptions toward newer alternatives. San Francisco’s Medivation (NASDAQ: MDVN ), co-owner of prostate cancer drug enzalutamide (Xtandi), remains biotech’s hottest target.

News 14

Ostendo Raising Funds to Advance Virtual Reality Display Technology

Xconomy

Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter. Razi, Bussel, and Dull are also on the board of Ingenu, the San Diego wireless technology company known previously as On-Ramp Wireless.

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

The filing held some surprises , however, as Xconomy reported: plans to convert about $200 million in debt—a massive amount for a privately held biotech—into shares at the IPO, with some of those shares holding special privileges for their owners. —Ben Fidler contributed to this report. right now.

News 14

San Diego's Mapp Bio Behind Experimental Ebola Drug

socalTECH

A San Diego-based biopharmaceuticals startup, Mapp Biopharmaceuticals , is the source of the experimental Ebola treatment that has been given to the two Americans who are being treated for the dreaded disease, according to CNN. Mapp Biopharmaceutical is backed by LeafBio, Defyrus Inc., the U.S. READ MORE>>.

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J. Bigelow contributed to this report.

How Will Apple Innovate Beyond the iPhone 7? With Next-Gen Siri

Xconomy

Apple’s iPhone 7 is due out next month. The biggest change: no more headphone plug. Redesigned iPhones typically come out in even-numbered years.

Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More

Xconomy

CARB-X will also run four accelerators—in San Francisco, Cambridge, MA, and two in the U.K. —Ben Fidler contributed to this report.

Study 19

Two San Diego Sites Rank Tops In Rising Social Networking Interest

socalTECH

Image courtesy Bigstock. READ MORE>>. social networking analysis pinterest experian skillwho stocktwits ranking

Study 11

How Cyber Visibility Protects Against the Abnormal & the Immoral

Xconomy

For many Bostonians, the “privacy incident” recently disclosed by Massachusetts General Hospital (MGH)—which reportedly involved the personal information of 4,300 dental patients stored by a software vendor—hit close to home in many ways, as most of us have at one time or another been to MGH for ourselves or a loved one.

Texas Looks To Steal Away Another San Diego Company, Omnitracs

socalTECH

According to reports, Omnitracs is in the midst of negotations to move its operations out of San Diego, and to Austin, following the recent sale of Omnitracs by Qualcomm to private equity firm Vista Equity Partners. texas diego omnitracs jobs employment READ MORE>>.

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. —At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves.

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

Xconomy

—The Associated Press reported that surgeon Paolo Macchiarini faces involuntary manslaughter charges in Sweden related to two patients who died after surgeries he conducted to implant artificial tracheas to replace their damaged windpipes. Savara now aims to pull together a funding round to support a future IPO, David Holley reports.

Study 20

Look Beyond Football to Fight Concussions

Xconomy

This is bad news for football, which has seen a steep drop in youth participation in recent years because of safety concerns. Follow @alexharding7.

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. —Buzzfeed ran a lengthy report Wednesday on the sexual harassment charges against University of Washington vaccine researcher Michael Katze.

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

San Carlos, CA-based BioCardia will also go public via a reverse merger , four months after dropping plans for an IPO. Morgan party.

Websense, After Move From San Diego, In Acquisition Talks

socalTECH

Former San Diego-based security software developer Websense > --one of a number of companies acquired by private equity investor Vista Equity Partners and moved out of San Diego--is now in talks to be acquired by Raytheon , according to a report. Websense was acquired by Vista Equity Partners in 2013. READ MORE>>.

Balancing Risks and Opportunities: The Board’s Perspective

Xconomy

Once risk professionals have a seat at the table, the onus is on them to report risk data to the board as effectively as possible. It’s also important to set a context for the issues that are reported. People start a business for many reasons. Some do it out of sheer passion, while others do it to create wealth and economic growth.

‘Megadeals’ Dominate Q2 as VCs Invest $15.3B, and Top 10 Deals

Xconomy

billion into 961 deals across the United States during the three months that ended June 30, according to the MoneyTree Report on venture capital activity. The MoneyTree Report is prepared by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters. San Francisco. San Diego.

New Report Details Technology Job Concentration In Region

socalTECH

The highest ranked was San Diego-Carlsbad-San Marcos , with 11.1 percent of jobs in technology, ranked at 20. READ MORE>>.

Xconomy’s Top Innovation Stories of the Half Year

Xconomy

Frank Vinluan reports from North Carolina on a new effort to boost agtech startups and university research. 8. San Antonio Entrepreneur Center Opens Using Dallas Nonprofit as Model. David Holley reports on an effort to boost San Antonio’s startup scene, with ideas from another part of the Lone Star State.

Sony Slashes Jobs In San Diego

socalTECH

The layoffs, which were first reported by GameSpot, also affected Sony Online Entertainment''s Austin operations. READ MORE>>.

LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal

Xconomy

LabCorp will also assume net debt of San Diego-based Sequenom (NASDAQ: SQNM ), bringing the value of the cash deal to approximately $371 million.

3D Robotics Shuts San Diego Office

socalTECH

Drone maker 3D Robotics , the high profile, consumer drone maker, has closed its San Diego offices and is now refocusing on the enterprise market, according to a number of reports. The move reportedly comes due to a slowdown at the Berkeley-based drone maker, due to intense competition from Chinese drone makers DJI.

Report: Uber Artificially Pushes Pricing In San Diego

socalTECH

According to a report Wednesday from TheVerge, Uber has been keeping drivers off the road in San Diego--to force "surge" pricing on the ride service. uber smartphone service mobile ride diego pricing manipulation controversey Is Uber manipulating the market for its UberX car service? READ MORE>>.